|
|
Volumn 252, Issue SUPPL. 3, 2005, Pages
|
|
10 Years of interferon beta-1b (Betaferon®) therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLATIRAMER;
INTERFERON BETA SERINE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE ACTIVITY;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG INDICATION;
DRUG RESPONSE;
DRUG SAFETY;
HUMAN;
IMMUNOMODULATION;
MORBIDITY;
MULTIPLE SCLEROSIS;
NERVOUS SYSTEM INJURY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OPTIMAL DRUG DOSE;
OUTCOMES RESEARCH;
PATENT;
PATHOGENESIS;
PHARMACOGENETICS;
PHARMACOGENOMICS;
PREDICTION;
PRIORITY JOURNAL;
PROTEOMICS;
TREATMENT INDICATION;
TREATMENT PLANNING;
ADJUVANTS, IMMUNOLOGIC;
CLINICAL TRIALS;
HUMANS;
INTERFERON-BETA;
MULTIPLE SCLEROSIS;
|
|
EID: 25144497029
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-005-2009-z Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (0)
|
